GlassScriptPhysician profile
Kiara D Brown
NPI 1770962953
$28,051.60
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $487 · 2021: $25K · 2023: $1,727 · 2024: $29.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,475 · Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,475.45 |
| Food and Beverage | $280.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $25,116.46 | 2020-2021 | |
| Zimvie INC. | $1,727.25 | 2023 | |
| Stryker Corporation | $695.26 | 2019-2020 | |
| Geistlich Pharma, North America, INC. | $184.78 | 2019 | |
| Axogen | $110.82 | 2019-2021 | |
| Biohorizons Implant Systems INC. | $90.06 | 2019 | |
| Zimmer Biomet Holdings, INC. | $82.78 | 2019-2020 | |
| Straumann USA LLC | $29.03 | 2024 | |
| Depuy Synthes Sales INC. | $15.16 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiara Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.